Date : October 31, 2023
Share on :

The Global Respiratory Care Devices Market is poised for substantial expansion of more than USD 35 Billion by 2028 driven by the escalating burden of respiratory diseases. Projections indicate a robust CAGR of over 7.8% from 2023 to 2028 for this dynamic

The Global Respiratory Care Devices Market is poised for substantial expansion of more than USD 35 Billion by 2028 driven by the escalating burden of respiratory diseases. Projections indicate a robust CAGR of over 7.8% from 2023 to 2028 for this dynamic
The global burden of respiratory diseases is an escalating health crisis, underscoring the critical need for advanced respiratory care devices. These diseases, which include chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and various forms of lung cancer, collectively affect millions of individuals worldwide, causing substantial morbidity and mortality. Factors such as air pollution, smoking, and viral outbreaks have exacerbated the prevalence and severity of these conditions. As a result, the demand for innovative respiratory care devices, such as ventilators, oxygen concentrators, nebulizers, and continuous positive airway pressure (CPAP) machines, has surged. These devices not only provide essential life support for acute respiratory distress but also improve the quality of life for those living with chronic conditions. As the global population continues to age and environmental challenges persist, the development and accessibility of these respiratory care devices are pivotal in mitigating the burden of respiratory diseases and improving public health outcomes. The WHO has a number of initiatives related to respiratory care, including the Global Initiative for Asthma (GINA), the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), and the Global Initiative for Tuberculosis (GITT). These initiatives provide evidence-based guidance on the prevention, diagnosis, and management of respiratory diseases. Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM): The GFATM supports countries to strengthen oxygen and respiratory care ecosystems, aiming for those most in need to access care and treatment services as soon as possible. Through its C19RM funding, the GFATM supports countries to bolster health infrastructure by providing medical oxygen and associated clinical and non-clinical products. Project Boxer is a GFATM initiative that supports implementation of medical oxygen programs through C19RM funding.

According to the research report, “Global Respiratory Care Devices Market Outlook, 2028” published by Bonafide Research, the market is anticipated to cross USD 35 Billion by 2028, increasing from USD 22.94 Billion in 2022. The market is expected to grow with 7.86% CAGR by 2023-28. Given the increasing significance of these devices in contemporary healthcare, the market for respiratory care devices is expanding dramatically on a global scale. As a result, there is an escalating need for advanced respiratory care devices that offer effective treatment and management options for patients. These devices are pivotal not only for life-threatening acute situations but also for the day-to-day well-being and comfort of individuals living with chronic respiratory conditions. The ongoing technological advancements in the field of respiratory care have also played a substantial role in market expansion. Innovations in device design, such as the development of portable and user-friendly devices, have made respiratory care more accessible and convenient for patients. Furthermore, the integration of smart technology and data analytics into these devices allows for better patient monitoring and personalized treatment plans. With telemedicine and remote patient monitoring on the rise, respiratory care devices have become essential tools for healthcare professionals to deliver timely and efficient care. Moreover, the aging global population has also contributed to the market's expansion. Elderly individuals are more susceptible to respiratory conditions, and as the population ages, the demand for respiratory care devices is expected to increase. The growth in home healthcare services, coupled with a shift toward proactive healthcare management, has further fueled the demand for portable, easy-to-use respiratory care devices that can be administered outside of traditional hospital settings.

Based on the geography, the Respiratory care devices market is segmented into regions; North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominates the market in 2022. This dominance can be attributed to a confluence of factors that position North America at the forefront of respiratory care device adoption and innovation. The region boasts a well-established and advanced healthcare infrastructure, characterized by a high degree of awareness regarding respiratory diseases and their management. With a significant patient pool suffering from conditions like COPD, asthma, and sleep apnea, there is a robust demand for respiratory care devices in North America. Along with this, Europe also holds the significant market share in 2022. Some of the most prominent companies contributing to the overall growth of market include, Koninklijke Philips N.V., Medtronic Inc, Masimo Corporation, Cardinal Health, Inc, Medline Industries, Baxter International Inc., Stryker Corporation, Siemens AG, and others. The Asia-Pacific respiratory care device market is benefiting from ongoing medical technology improvements. Innovative products that are more user-friendly, portable, and efficient are being developed by manufacturers. Among the cutting-edge technologies making respiratory care more accessible and convenient for patients in the region are smart inhalers, portable oxygen concentrators, and telehealth options.

The market is segmented based on Product Type, into Therapeutic Devices, Monitoring Devices, Diagnostic Devices, and Consumables and Accessories. The therapeutic device segment did indeed dominate the global market for respiratory care equipment. A variety of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and others, require the use of respiratory care devices. Due to the frequency of respiratory ailments, therapeutic devices play a significant part in treating respiratory conditions and are frequently in great demand. Inhalers, ventilators, Positive Airways Pressure (PAP) equipment, humidifiers, nebulizers, and other products (oxygen concentrators, oxygen hoods), are some of the popular therapeutic equipment on the market. Globally, the population is aging quickly, and chronic respiratory disorders are more common in elderly people. Using nebulizers and inhalers to deliver medicine straight to the lungs is efficient and practical. The report is divided into monitoring equipment, such as gas analyzers and pulse oximeters. Over the years, a number of factors have contributed to the tremendous growth and diversity of the global pulse Oximeter and gas analyzer market. Particularly in light of the COVID-19 epidemic, pulse oximeters, which are primarily used to detect oxygen saturation levels in the blood, have become extremely popular since they provide a quick and painless way to keep track on respiratory health. Based on the diagnostics devices, the market is categorized into Spirometers, Polysomnography Devices, and Peak Flow meters. Spirometers are vital diagnostic tools used to measure lung function and airflow, making them essential for assessing various respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases. The dominance of spirometers in this market can be attributed to their accuracy, ease of use, and widespread adoption in clinical settings, including hospitals, clinics, and primary care facilities. Based on the consumables and accessories of respiratory care devices, the market is further distinguished into Disposable Resuscitators, Breathing Circuits, Masks, Tracheostomy Tubes, and Others (Nasal Cannulas). In the global market for medical equipment, disposable resuscitators did hold a considerable market share. In emergency medical care, disposable resuscitators, also known as bag-valve masks, are essential, especially in instances where immediate ventilation support is needed, such as cardiac arrests, trauma cases, or respiratory distress conditions. There are a number of important variables that contribute to their market domination.

According to disease indications, the respiratory care devices market is segmented, and this division offers important insights into the particular medical problems that are driving demand for these devices. Chronic Obstructive Pulmonary illness (COPD) dominates the other illness categories, making a considerable contribution to the market's size and expansion. Since COPD is becoming more common, it is now a problem for world health. Nebulizers, ventilators, and portable oxygen concentrators are frequently needed by COPD patients in order to control their symptoms, ease breathing problems, and enhance their quality of life. Following closely behind COPD, Sleep Apnea is the second most prominent disease indication in the respiratory care devices market. Sleep Apnea is a sleep disorder characterized by intermittent cessation of breathing during sleep, leading to a range of health issues. The treatment of sleep apnea frequently involves the use of Continuous Positive Airway Pressure (CPAP) machines, adaptive servo-ventilation devices, and other respiratory care equipment, contributing substantially to the market's growth.

The market segmentation based on end-users, which includes hospitals, ambulatory care centers (ACCs), home care settings, and other end-users, demonstrates the diversity and dynamic nature of the global market for respiratory care equipment. Hospitals unquestionably have the biggest market share among these sectors, partly because respiratory care devices are heavily used in inpatient settings. Hospitals serve as the forefront of healthcare, treating a range of respiratory conditions as well as acute exacerbations of chronic illnesses like COPD and the urgent needs of patients in emergency departments. Because of the crucial role that respiratory care devices play in these high-acuity scenarios, where rapid and precise intervention might mean the difference between life and death, they are widely used. Ambulatory care centers (ACCs), which serve as outpatient care providers, come in second in terms of market share. ACCs are equipped with respiratory care equipment to better handle patients with a variety of respiratory disorders than traditional hospitals are. The management of chronic diseases requires the use of these facilities, which also do routine check-ups and treatments. Respiratory care equipment is widely used to monitor and help patients with conditions like asthma, bronchitis, and sleep apnea. Another large market sector is the home care settings.

Bonafide Logo

The Global Respiratory Care Devices Market is poised for substantial expansion of more than USD 35 Billion by 2028 driven by the escalating burden of respiratory diseases. Projections indicate a robust CAGR of over 7.8% from 2023 to 2028 for this dynamic

  • Share on :

Contact usWe are friendly and approachable, give us a call.